139 related articles for article (PubMed ID: 11881817)
21. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
[TBL] [Abstract][Full Text] [Related]
22. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation.
Rufer N; Wolpert E; Helg C; Tiercy JM; Gratwohl A; Chapuis B; Jeannet M; Goulmy E; Roosnek E
Transplantation; 1998 Oct; 66(7):910-6. PubMed ID: 9798702
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel minor histocompatibility antigens responsible for graft-versus-leukemia (GVL) effect on chronic myeloid leukemia: usefulness of determining the clonotype of T cells associated with GVL effect after donor leukocyte infusion.
Nakao S
Int J Hematol; 2002 Aug; 76 Suppl 1():274-6. PubMed ID: 12430863
[TBL] [Abstract][Full Text] [Related]
24. [T clones, a means of exploring minor antigens involved in graft versus host reaction].
Miconnet I
Presse Med; 1992 Dec; 21(41):1947-50. PubMed ID: 1294947
[TBL] [Abstract][Full Text] [Related]
25. Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantation.
Warren EH; Gavin M; Greenberg PD; Riddell SR
Curr Opin Hematol; 1998 Nov; 5(6):429-33. PubMed ID: 9814651
[TBL] [Abstract][Full Text] [Related]
26. Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation.
Mori S; El-Baki H; Mullen CA
Bone Marrow Transplant; 2003 May; 31(10):865-75. PubMed ID: 12748663
[TBL] [Abstract][Full Text] [Related]
27. Minor transplantation antigens: animal models for human host-versus-graft, graft-versus-host, and graft-versus-leukemia reactions.
Simpson E
Transplantation; 1998 Mar; 65(5):611-6. PubMed ID: 9521192
[No Abstract] [Full Text] [Related]
28. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
Terakura S; Murata M; Warren EH; Sette A; Sidney J; Naoe T; Riddell SR
Transplantation; 2007 May; 83(9):1242-8. PubMed ID: 17496542
[TBL] [Abstract][Full Text] [Related]
29. Biochemical and immunogenetic analysis of an immunodominant peptide (B6dom1) encoded by the classical H7 minor histocompatibility locus.
Eden PA; Christianson GJ; Fontaine P; Wettstein PJ; Perreault C; Roopenian DC
J Immunol; 1999 Apr; 162(8):4502-10. PubMed ID: 10201988
[TBL] [Abstract][Full Text] [Related]
30. Graft-versus-leukemia effect in minor antigen mismatched chimeras given delayed donor leucocyte infusion: immunoregulatory aspects and role of donor T and ASGM1-positive cells.
Sefrioui H; Billiau AD; Waer M
Transplantation; 2000 Jul; 70(2):348-53. PubMed ID: 10933162
[TBL] [Abstract][Full Text] [Related]
31. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
[TBL] [Abstract][Full Text] [Related]
32. Minor Histocompatibility Antigen-Specific T Cells.
Summers C; Sheth VS; Bleakley M
Front Pediatr; 2020; 8():284. PubMed ID: 32582592
[TBL] [Abstract][Full Text] [Related]
33.
Bykova NA; Malko DB; Efimov GA
Front Immunol; 2018; 9():1819. PubMed ID: 30166983
[TBL] [Abstract][Full Text] [Related]
34. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens.
Korngold R; Leighton C; Mobraaten LE; Berger MA
Biol Blood Marrow Transplant; 1997 Jun; 3(2):57-64. PubMed ID: 9267665
[TBL] [Abstract][Full Text] [Related]
35. A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications.
Spierings E; Drabbels J; Hendriks M; Pool J; Spruyt-Gerritse M; Claas F; Goulmy E
PLoS One; 2006 Dec; 1(1):e42. PubMed ID: 17183671
[TBL] [Abstract][Full Text] [Related]
36. Histocompatibility influence in allogeneic marrow transplantation therapy of murine viral leukemia. I.--Studies of the relative influence of major versus minor histocompatibility determinants.
Meredith RF; Okunewick JP; Raikow RB; Brozovich BJ; Seeman PR; Magliere KC
Biomedicine; 1981 Feb; 34(1):11-7. PubMed ID: 7013840
[TBL] [Abstract][Full Text] [Related]
37. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
38. Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.
Perreault C; Jutras J; Roy DC; Filep JG; Brochu S
J Clin Invest; 1996 Aug; 98(3):622-8. PubMed ID: 8698852
[TBL] [Abstract][Full Text] [Related]
39. Rapid Multiplex Genotyping of 20 HLA-A
Romaniuk DS; Postovskaya AM; Khmelevskaya AA; Malko DB; Efimov GA
Front Immunol; 2019; 10():1226. PubMed ID: 31275297
[TBL] [Abstract][Full Text] [Related]
40. The H4b minor histocompatibility antigen is caused by a combination of genetically determined and posttranslational modifications.
Yadav R; Yoshimura Y; Boesteanu A; Christianson GJ; Ajayi WU; Shashidharamurthy R; Stanic AK; Roopenian DC; Joyce S
J Immunol; 2003 May; 170(10):5133-42. PubMed ID: 12734360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
